CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,589 enrolled
Drug / intervention
An informational packet regarding shingles and the HZV was sent to patients identified by the EMRother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01519570
NCT01519570N/ACompleted

Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates

Ohio State University·interventional·Posted Jan 27, 2012·Updated Feb 1, 2019

In Brief

A clinical study evaluating An informational packet regarding shingles and the HZV was sent to patients identified by the EMR for Herpes Zoster Disease. Completed, enrolled 2,589 participants across 1 site.

Detailed Summary

Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 27, 2012
Enrollment StartMar 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.4 years ago

Interventions

An informational packet regarding shingles and the HZV was sent to patients identified by the EMRother

The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.